Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide
0.1.0 - CI Build
Vulcan ePI FHIR Implementation Guide - Local Development build (v0.1.0). See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="cfsb1651597532341"/>
<identifier>
<system value="https://www.gravitatehealth.eu/sid/doc"/>
<value value="EU/1/19/1370/001"/>
</identifier>
<type value="document"/>
<timestamp value="2011-06-23T08:38:00+02:00"/>
<entry>
<resource>
<Composition>
<id value="cfsb1651234995610"/>
<language value="es"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml" xml:lang="es" lang="es"><p><b>Generated Narrative: Composition</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Composition "cfsb1651234995610" (Language "es") </p></div><p><b>status</b>: final</p><p><b>type</b>: Package Leaflet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000155538)</span></p><p><b>date</b>: 2022-04-29 01:28:17+0000</p><p><b>author</b>: <a href="#Organization_cfsb1651149636159">See above (Organization/cfsb1651149636159)</a></p><p><b>title</b>: TEST PURPOSES ONLY/EJEMPLO DE PRUEBAS - Dovato 50 mg/300 mg comprimidos recubiertos con película</p><p><b>confidentiality</b>: U</p><h3>Attesters</h3><table class="grid"><tr><td>-</td><td><b>Mode</b></td><td><b>Time</b></td></tr><tr><td>*</td><td>Official <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-composition-attestation-mode.html">CompositionAttestationMode</a>#official)</span></td><td>2002-08-01 01:28:17+0000</td></tr></table></div>
</text>
<status value="final"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538"/>
</coding>
<text value="Package Leaflet"/>
</type>
<subject>
<reference value="RegulatedAuthorization/cfsb1651148079894"/>
</subject>
<date value="2022-04-29T13:28:17Z"/>
<author>
<reference value="Organization/cfsb1651149636159"/>
</author>
<title
value="TEST PURPOSES ONLY/EJEMPLO DE PRUEBAS - Dovato 50 mg/300 mg comprimidos recubiertos con película"/>
<confidentiality value="U"/>
<attester>
<mode>
<coding>
<system value="http://hl7.org/fhir/composition-attestation-mode"/>
<code value="official"/>
</coding>
</mode>
<time value="2002-08-01T13:28:17Z"/>
</attester>
<section>
<title value="B. Package Leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Prospecto: información para el paciente Dovato 50 mg/300 mg comprimidos recubiertos con película dolutegravir/lamivudina <b>Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.</b><ul><li>Conserve este prospecto, ya que puede tener que volver a leerlo.</li><li>Si tiene alguna duda, consulte a su médico o farmacéutico.</li><li>Este medicamento se le ha recetado solamente a usted, y no debe dárselo a otras personas aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.</li><li>Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.</li></ul></div>
</text>
</section>
<section>
<title value="What is in this leaflet"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-0"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml">Contenido del prospecto<ol><li>Qué es Dovato y para qué se utiliza</li><li>Qué necesita saber antes de empezar a tomar Dovato</li><li>Cómo tomar Dovato</li><li>Posibles efectos adversos</li><li>Conservación de Dovato</li><li>Contenido del envase e información adicional</li></ol></div>
</text>
</section>
<section>
<title value="1. What Dovato is and what it is used for"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-1"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><b>1. Qué es Dovato y para qué se utiliza</b> Dovato es un medicamento que contiene dos principios activos usados para tratar la infección por el virus de la inmunodeficiencia humana (VIH): dolutegravir y lamivudina. Dolutegravir pertenece al grupo de medicamentos antirretrovirales llamados inhibidores de la integrasa (INI) y lamivudina pertenece a un grupo de medicamentos antirretrovirales denominados inhibidores de la transcriptasa inversa análogos de nucleósido (ITIAN).</div>
</text>
</section>
<section>
<title value="2. What you need to know before you take Dovato"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-2"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><b>2. Qué necesita saber antes de empezar a tomar Dovato</b> <b>No tome Dovato</b><ul><li>si es <b>alérgico</b> (hipersensible) a dolutegravir o lamivudina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6)</li><li>si está tomando un medicamento llamado <b>fampridina</b> (también conocido como dalfampridina; utilizado para tratar la esclerosis múltiple).</li></ul></div>
</text>
</section>
<section>
<title value="3. How to take Dovato"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-3"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><b>3. Cómo tomar Dovato</b><p>Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.</p><ul><li>La dosis recomendada de Dovato es <b>un comprimido una vez al día.</b></li></ul><p>Trague el comprimido con un poco de líquido. Dovato se puede tomar con o sin alimentos.</p></div>
</text>
</section>
<section>
<title value="4. Possible side effects"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-4"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>4. Posibles efectos adversos</b></p><p>Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran, <b>por lo que es muy importante que le comente a su médico cualquier cambio en su estado de salud.</b></p></div>
</text>
</section>
<section>
<title value="5. How to store Dovato"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-5"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><b>5. Conservación de Dovato</b><p>Mantener este medicamento fuera de la vista y del alcance de los niños</p><p>No utilice este medicamento después de la fecha de caducidad que aparece en la caja y el frasco después de CAD. La fecha de caducidad es el último día del mes que se indica.</p><p>Este medicamento no requiere ninguna condición especial de conservación.</p><p>Los medicamentos no se deben tirar por los desagües ni a la basura. Pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que ya no necesita. De esta forma, ayudará a proteger el medio ambiente.</p></div>
</text>
</section>
<section>
<title value="6. Contents of the pack and other information"/>
<code>
<coding>
<system value="https://spor.ema.europa.eu/"/>
<code value="100000155538-6"/>
</coding>
<text value="B. PACKAGE LEAFLET"/>
</code>
<text>
<status value="additional"/>
<div xmlns="http://www.w3.org/1999/xhtml"><b>6. Contenido del envase e información adicional</b> <b>Composición de Dovato</b><ul><li>Los principios activos son dolutegravir y lamivudina. Cada comprimido contiene dolutegravir sódico equivalente a 50 mg de dolutegravir y 300 mg de lamivudina.</li><li>Los demás componentes son celulosa microcristalina, carboximetilalmidón sódico, estearato de magnesio, manitol (E421), povidona (K29/32), fumarato estearilo de sodio, hipromelosa (E464), macrogol, dióxido de titanio (E171).</li><li>Este medicamento contiene menos de 1 mmol de sodio (23 mg) por comprimido; esto es, esencialmente “exento de sodio”.</li></ul></div>
</text>
</section>
</Composition>
</resource>
</entry>
<entry>
<resource>
<Organization>
<id value="cfsb1650997423990"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization "cfsb1650997423990" </p></div><p><b>identifier</b>: id: ORG-100004538 (OFFICIAL), id: LOC-100000153 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: manufacturer <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#220000000033)</span></p><p><b>name</b>: GLAXO WELLCOME, S.A.</p><p><b>address</b>: Avda. Extremadura, 3(WORK)</p></div>
</text>
<identifier>
<use value="official"/>
<system value="$spor-org"/>
<value value="ORG-100004538"/>
</identifier>
<identifier>
<use value="official"/>
<system value="$spor-org"/>
<value value="LOC-100000153"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000033"/>
</coding>
<text value="manufacturer"/>
</type>
<name value="GLAXO WELLCOME, S.A."/>
<address>
<use value="work"/>
<type value="physical"/>
<text value="Avda. Extremadura, 3"/>
<line value="Avda. Extremadura 3, 09400 Aranda De Duero"/>
<city value="Aranda De Duero"/>
<country value="ES"/>
</address>
</Organization>
</resource>
</entry>
<entry>
<resource>
<Organization>
<id value="cfsb1651152112409"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization "cfsb1651152112409" </p></div><p><b>identifier</b>: id: ORG-100013412 (OFFICIAL), id: LOC-100020264 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Medicines Regulatory Authority <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#220000000032)</span></p><p><b>name</b>: European Medicines Agency</p><p><b>address</b>: Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands(WORK)</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100013412"/>
</identifier>
<identifier>
<use value="official"/>
<system value="$spor-org"/>
<value value="LOC-100020264"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="/#220000000032"/>
</coding>
<text value="Medicines Regulatory Authority"/>
</type>
<name value="European Medicines Agency"/>
<address>
<use value="work"/>
<type value="physical"/>
<text
value="Domenico Scarlattilaan 6 1083 HS Amsterdam The Netherlands"/>
<line
value="Carretera De Martorell 41 61, Poligono Industrial Nord-Est"/>
<city value="Amsterdam"/>
<postalCode value="1083 HS"/>
<country value="nl"/>
</address>
</Organization>
</resource>
</entry>
<entry>
<resource>
<Organization>
<id value="cfsb1651149636159"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Organization</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Organization "cfsb1651149636159" </p></div><p><b>identifier</b>: id: ORG-100012958 (OFFICIAL)</p><p><b>active</b>: true</p><p><b>type</b>: Marketing authorisation holder <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#220000000034)</span></p><p><b>name</b>: ViiV Healthcare BV</p><p><b>address</b>: Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands(WORK)</p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/omswi"/>
<value value="ORG-100012958"/>
</identifier>
<active value="true"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000034"/>
<display value="Marketing authorisation holder"/>
</coding>
<text value="Marketing authorisation holder"/>
</type>
<name value="ViiV Healthcare BV"/>
<address>
<use value="work"/>
<type value="physical"/>
<text
value="Van Asch van Wijckstraat 55H 3811 LP Amersfoort Netherlands"/>
<line value="Van Asch van Wijckstraat 55H"/>
<city value="Amersfoort"/>
<country value="NL"/>
</address>
</Organization>
</resource>
</entry>
<entry>
<resource>
<RegulatedAuthorization>
<id value="cfsb1651148079894"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: RegulatedAuthorization</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource RegulatedAuthorization "cfsb1651148079894" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>subject</b>: <a href="#MedicinalProductDefinition_cfsb1650904258324">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>type</b>: Marketing Authorisation <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#100000072062)</span></p><p><b>region</b>: European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2019-07-01 01:28:17+0000</p><p><b>holder</b>: <a href="#Organization_cfsb1651149636159">See above (Organization/cfsb1651149636159)</a></p><p><b>regulator</b>: <a href="#Organization_cfsb1651152112409">See above (Organization/cfsb1651152112409)</a></p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="EU/1/19/1370/001"/>
</identifier>
<subject>
<reference value="MedicinalProductDefinition/cfsb1650904258324"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072062"/>
</coding>
<text value="Marketing Authorisation"/>
</type>
<region>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="eu"/>
</coding>
<text value="European Union"/>
</region>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
</coding>
<text value="Active"/>
</status>
<statusDate value="2019-07-01T13:28:17Z"/>
<holder>
<reference value="Organization/cfsb1651149636159"/>
</holder>
<regulator>
<reference value="Organization/cfsb1651152112409"/>
</regulator>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<resource>
<MedicinalProductDefinition>
<id value="cfsb1650904258324"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicinalProductDefinition</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicinalProductDefinition "cfsb1650904258324" </p></div><p><b>identifier</b>: id: 498163</p><p><b>type</b>: Medicinal Product <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-medicinal-product-type.html">MedicinalProductType</a>#MedicinalProduct)</span></p><p><b>domain</b>: Human use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-medicinal-product-domain.html">MedicinalProductDomain</a>#Human)</span></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>legalStatusOfSupply</b>: Medicinal product subject to medical prescription <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#100000072084)</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Dovato 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Full name <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#220000000001)</span></p><h3>NameParts</h3><table class="grid"><tr><td>-</td><td><b>Part</b></td><td><b>Type</b></td></tr><tr><td>*</td><td>film-coated tablets</td><td>Pharmaceutical dose form part <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#220000000005)</span></td></tr></table><h3>CountryLanguages</h3><table class="grid"><tr><td>-</td><td><b>Country</b></td><td><b>Jurisdiction</b></td><td><b>Language</b></td></tr><tr><td>*</td><td>European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></td><td>European Union <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (unknown#eu)</span></td><td>English <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/3.0.0/CodeSystem-v3-ietf3066.html">Tags for the Identification of Languages</a>#en)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="498163"/>
</identifier>
<type>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-type"/>
<code value="MedicinalProduct"/>
</coding>
<text value="Medicinal Product"/>
</type>
<domain>
<coding>
<system value="http://hl7.org/fhir/medicinal-product-domain"/>
<code value="Human"/>
</coding>
<text value="Human use"/>
</domain>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000072084"/>
</coding>
<text value="Medicinal product subject to medical prescription"/>
</legalStatusOfSupply>
<name>
<productName value="Dovato 50 mg/300 mg film-coated tablets"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000001"/>
</coding>
<text value="Full name"/>
</type>
<namePart>
<part value="film-coated tablets"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="220000000005"/>
</coding>
<text value="Pharmaceutical dose form part"/>
</type>
</namePart>
<countryLanguage>
<country>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="eu"/>
</coding>
<text value="European Union"/>
</country>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="eu"/>
</coding>
<text value="European Union"/>
</jurisdiction>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="en"/>
</coding>
<text value="English"/>
</language>
</countryLanguage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<resource>
<PackagedProductDefinition>
<id value="cfsb1650995718524"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: PackagedProductDefinition</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource PackagedProductDefinition "cfsb1650995718524" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>name</b>: Dovato 50 mg/300 mg film-coated tablets</p><p><b>type</b>: Chemical Medicinal Prodcut <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#100000155527)</span></p><p><b>packageFor</b>: <a href="#MedicinalProductDefinition_cfsb1650904258324">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>status</b>: Active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://build.fhir.org/codesystem-publication-status.html">PublicationStatus</a>#active)</span></p><p><b>statusDate</b>: 2012-02-07 01:28:17+0000</p><p><b>containedItemQuantity</b>: 30 tablets</p><p><b>manufacturer</b>: <a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></p><h3>Packages</h3><table class="grid"><tr><td>-</td><td><b>Identifier</b></td><td><b>Type</b></td><td><b>Quantity</b></td><td><b>Material</b></td></tr><tr><td>*</td><td>id: 654321</td><td>Child-resistant closure <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#100000073504)</span></td><td>1</td><td>Cardboard <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#200000003529)</span></td></tr></table></div>
</text>
<identifier>
<use value="official"/>
<system value="$spor-prod"/>
<value value="EU/1/19/1370/001"/>
</identifier>
<name value="Dovato 50 mg/300 mg film-coated tablets"/>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000155527"/>
</coding>
<text value="Chemical Medicinal Prodcut"/>
</type>
<packageFor>
<reference value="MedicinalProductDefinition/cfsb1650904258324"/>
</packageFor>
<status>
<coding>
<system value="http://hl7.org/fhir/publication-status"/>
<code value="active"/>
<display value="Active"/>
</coding>
</status>
<statusDate value="2012-02-07T13:28:17Z"/>
<containedItemQuantity>
<value value="30"/>
<unit value="tablets"/>
</containedItemQuantity>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
<package>
<identifier>
<system value="https://spor.ema.europa.eu/pmswi"/>
<value value="654321"/>
</identifier>
<type>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="100000073504"/>
<display value="Child-resistant closure"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
</package>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<resource>
<AdministrableProductDefinition>
<id value="cfsb1650999516847"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: AdministrableProductDefinition</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource AdministrableProductDefinition "cfsb1650999516847" </p></div><p><b>identifier</b>: id: 123456</p><p><b>status</b>: active</p><p><b>formOf</b>: <a href="#MedicinalProductDefinition_cfsb1650904258324">See above (MedicinalProductDefinition/cfsb1650904258324)</a></p><p><b>administrableDoseForm</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#10219000)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#15054000)</span></p><p><b>producedFrom</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><blockquote><p><b>routeOfAdministration</b></p><p><b>code</b>: Oral use <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#20053000)</span></p><h3>TargetSpecies</h3><table class="grid"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Human <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#/#100000109093)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="https://www.who-umc.org/phpid"/>
<value value="123456"/>
</identifier>
<status value="active"/>
<formOf>
<reference value="MedicinalProductDefinition/cfsb1650904258324"/>
</formOf>
<administrableDoseForm>
<coding>
<system
value="https://standardterms.edqm.eu/browse/get_concepts_by/SOM/SOM/"/>
<code value="10219000"/>
</coding>
<text value="Tablet"/>
</administrableDoseForm>
<unitOfPresentation>
<coding>
<system
value="https://standardterms.edqm.eu/browse/get_concepts/UOP/"/>
<code value="15054000"/>
</coding>
<text value="Tablet"/>
</unitOfPresentation>
<producedFrom>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</producedFrom>
<routeOfAdministration>
<code>
<coding>
<system
value="https://standardterms.edqm.eu/browse/get_concepts/ROA/"/>
<code value="20053000"/>
</coding>
<text value="Oral use"/>
</code>
<targetSpecies>
<code>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="/#100000109093"/>
</coding>
<text value="Human"/>
</code>
</targetSpecies>
</routeOfAdministration>
</AdministrableProductDefinition>
</resource>
</entry>
<entry>
<resource>
<ManufacturedItemDefinition>
<id value="cfsb1650998521654"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ManufacturedItemDefinition</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ManufacturedItemDefinition "cfsb1650998521654" </p></div><p><b>identifier</b>: id: EU/1/19/1370/001 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>manufacturedDoseForm</b>: Film-coated tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000073665)</span></p><p><b>unitOfPresentation</b>: Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="CodeSystem-CodeSystemUvEPIRrmswi.html">Referentials Management Services CodeSystem</a>#200000002152)</span></p><p><b>manufacturer</b>: <a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></p></div>
</text>
<identifier>
<use value="official"/>
<system value="https://spor.ema.europa.eu/pmswi/#/"/>
<value value="EU/1/19/1370/001"/>
</identifier>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000073665"/>
</coding>
<text value="Film-coated tablet"/>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/rmswi"/>
<code value="200000002152"/>
</coding>
<text value="Tablet"/>
</unitOfPresentation>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</ManufacturedItemDefinition>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651162710491"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651162710491" </p></div><p><b>identifier</b>: id: 1Q1V9V5WYQ (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#00000072072)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class="grid"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>50 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (v3-RoleClassIngredientEntity##ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="1Q1V9V5WYQ"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="00000072072"/>
</coding>
<text value="active"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="1Q1V9V5WYQ"/>
<display value="DOLUTEGRAVIR SODIUM"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="50"/>
<unit value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity"/>
<code value="#ACTIB"/>
</coding>
<text value="active ingredient - basis of strength"/>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651164758053"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651164758053" </p></div><p><b>identifier</b>: id: 2T8Q726O95 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: active <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000072072)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p><h3>Strengths</h3><table class="grid"><tr><td>-</td><td><b>Presentation[x]</b></td><td><b>Basis</b></td></tr><tr><td>*</td><td>300 mg</td><td>active ingredient - basis of strength <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (v3-RoleClassIngredientEntity##ACTIB)</span></td></tr></table></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="2T8Q726O95"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000072072"/>
</coding>
<text value="active"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="2T8Q726O95"/>
<display value="lamivudine"/>
</coding>
</concept>
</code>
<strength>
<presentationQuantity>
<value value="300"/>
<unit value="mg"/>
</presentationQuantity>
<basis>
<coding>
<system
value="http://terminology.hl7.org/ValueSet/v3-RoleClassIngredientEntity"/>
<code value="#ACTIB"/>
</coding>
<text value="active ingredient - basis of strength"/>
</basis>
</strength>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651170791283"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651170791283" </p></div><p><b>identifier</b>: id: OP1R32D61U (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000072082)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="OP1R32D61U"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000072082"/>
</coding>
<text value="Excipient"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="OP1R32D61U"/>
<display value="microcrystalline cellulose"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651229974487"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651229974487" </p></div><p><b>identifier</b>: id: H8AV0SQX4D (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000072082)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="H8AV0SQX4D"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000072082"/>
</coding>
<text value="Excipient"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="H8AV0SQX4D"/>
<display value="sodium starch glycolate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651230170831"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651230170831" </p></div><p><b>identifier</b>: id: 70097M6I30 (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000072082)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="70097M6I30"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000072082"/>
</coding>
<text value="Excipient"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="70097M6I30"/>
<display value="magnesium stearate"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
<entry>
<resource>
<Ingredient>
<id value="cfsb1651230330246"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: Ingredient</b></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource Ingredient "cfsb1651230330246" </p></div><p><b>identifier</b>: id: 3OWL53L36A (OFFICIAL)</p><p><b>status</b>: active</p><p><b>for</b>: <a href="#ManufacturedItemDefinition_cfsb1650998521654">See above (ManufacturedItemDefinition/cfsb1650998521654)</a></p><p><b>role</b>: Excipient <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (#100000072082)</span></p><h3>Manufacturers</h3><table class="grid"><tr><td>-</td><td><b>Manufacturer</b></td></tr><tr><td>*</td><td><a href="#Organization_cfsb1650997423990">See above (Organization/cfsb1650997423990)</a></td></tr></table><blockquote><p><b>substance</b></p></blockquote></div>
</text>
<identifier>
<use value="official"/>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<value value="3OWL53L36A"/>
</identifier>
<status value="active"/>
<for>
<reference value="ManufacturedItemDefinition/cfsb1650998521654"/>
</for>
<role>
<coding>
<system value="https://spor.ema.europa.eu/rmswi/"/>
<code value="100000072082"/>
</coding>
<text value="Excipient"/>
</role>
<manufacturer>
<manufacturer>
<reference value="Organization/cfsb1650997423990"/>
</manufacturer>
</manufacturer>
<substance>
<code>
<concept>
<coding>
<system value="https://gsrs.ncats.nih.gov/ginas/app/beta/"/>
<code value="3OWL53L36A"/>
<display value="mannitol"/>
</coding>
</concept>
</code>
</substance>
</Ingredient>
</resource>
</entry>
</Bundle>
IG © 2021+ . Package hl7.fhir.uv.vulcan-epi#0.1.0 based on FHIR 5.0.0-snapshot1. Generated 2022-09-02
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change